Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Psychotherapy × 90 days × Clear all

Phase

Status

Not yet recruiting 2 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1

Conditions

Interventions

pembrolizumab 69 Cyclophosphamide 42 Nivolumab 40 Cisplatin 36 Carboplatin 32 Paclitaxel 29 Radiotherapy 24 Gemcitabine 23 Dexamethasone 22 fludarabine 21 Ipilimumab 20 Blood Specimen Collection 19 Cetuximab 18 atezolizumab 17 Doxorubicin 17 Docetaxel 17 Surveys and Questionnaires 16 Standard of Care 16 Prednisone 16 Lenalidomide 16 Irinotecan 16 Fluorouracil 15 lenvatinib 14 Trastuzumab 14 Oxaliplatin 14 regorafenib 13 Rituximab 13 Pemetrexed 13 Etoposide 13 Cytarabine 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04950608 2026-02-17

PATH

Dana-Farber Cancer Institute

Phase 2 Completed

15 enrolled 26 charts

Hospice

Data powered by HemOnc (CC BY 4.0) Colophon ⚡